SCHEMBL20164648

SCHEMBL20164648

CCCNc1nc(Cl)nc2c(NCC(C)(C)O)nc(Cl)nc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
SLC29A1 Q99808 4/20 0.41
PDE10A Q9Y233 1/20 0.36
HDAC1 Q13547 5/20 0.35
HDAC2 Q92769 5/20 0.35
HDAC3 O15379 4/20 0.35
HDAC4 P56524 4/20 0.35
HDAC7 Q8WUI4 4/20 0.35
HDAC10 Q969S8 4/20 0.35
HDAC11 Q96DB2 4/20 0.35
HDAC8 Q9BY41 4/20 0.35
HDAC6 Q9UBN7 4/20 0.35
HDAC9 Q9UKV0 4/20 0.35
HDAC5 Q9UQL6 4/20 0.35
NCOR2 Q9Y618 1/20 0.35
NR1I2 O75469 1/20 0.33
AHR P35869 1/20 0.33
TLR7 Q9NYK1 3/20 0.32
TLR8 Q9NR97 2/20 0.32
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16094375 0.85 SLC29A1 (0.47) KMT2ASLC29A1PDE10AHDAC1HDAC2
SCHEMBL20164422 0.84 ESR1 (0.33) ESR1
SCHEMBL20164638 0.80 SLC29A1 (0.54) KMT2ASLC29A1PDE10AHDAC1HDAC2
SCHEMBL20164475 0.80 SLC29A1 (0.44) KMT2ASLC29A1PDE10ATLR7TLR8
SCHEMBL20164502 0.80 SLC29A1 (0.48) KMT2ASLC29A1TLR7TLR8LMNA
SCHEMBL20164582 0.80 ALDH1A1 (0.35) KMT2ALMNA
SCHEMBL20164579 0.80 ALDH1A1 (0.35) KMT2ALMNA
SCHEMBL20164670 0.80 ALDH1A1 (0.35) KMT2ALMNA
SCHEMBL20164626 0.79 KMT2A (0.44) KMT2ASLC29A1PDE10AHDAC1HDAC2
Hydrochloric Acid SCHEMBL20164610 0.79 SLC29A1 (0.47) KMT2ASLC29A1TLR7TLR8LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3316890-B1 NOVEL BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF MAKING AND USING SAME NEURAD LTD (IL) 2023-09-06 EP disclosed
US-10294228-B2 Breathing control modulating compounds, and methods of making and using same NEURAD LTD. (IL) 2019-05-21 US disclosed
US-20180141953-A1 Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same NEURAD LTD. (IL) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141953-A1 Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same MTNR1B, CHRM3, PER2 KMT2A 2456/4885SLC29A1 4472/4885PDE10A 154/4885
US-10294228-B2 Breathing control modulating compounds, and methods of making and using same MTNR1B, PDE3A, CHRM3 KMT2A 2528/4885SLC29A1 4518/4885PDE10A 192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.